Literature DB >> 1523289

Focal manifestations of diffuse liver disease at MR imaging.

D G Mitchell1.   

Abstract

Detection and exclusion of focal liver lesions is especially difficult in patients with diffuse liver disease. Magnetic resonance (MR) imaging may be particularly valuable in these patients. By judicious comparison of appropriate pulse sequences, normal and hypertrophic liver may be distinguished from atrophic, neoplastic, or otherwise abnormal hepatic parenchyma. Chemical shift (lipid-sensitive) techniques allow definitive identification of fatty liver, including focal fatty infiltration or focal sparing. T2-weighted and T2*-weighted images allow identification of iron overload, depicting malignancies as focal masses without iron. Analysis of signal intensity and internal morphology allows confident distinction between regenerative nodules and hepatocellular carcinoma in most instances, and allows diagnosis of early carcinoma within regenerative nodules. MR imaging provides capabilities for noninvasive characterization of liver tissue beyond those available with other noninvasive modalities.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1523289     DOI: 10.1148/radiology.185.1.1523289

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

Review 1.  Acute non-traumatic maternal illnesses in pregnancy: imaging approaches.

Authors:  Saween K S Thompson; Stanford M Goldman; Komal B Shah; Phebe C Chen; Louis K Wagner; Frank M Corl; Bharat K Raval; Shela Sheth; Elliot K Fishman; Carl M Sandler
Journal:  Emerg Radiol       Date:  2005-06

2.  Impaired visibility of the hepatic veins on the multi-detector computed tomography in patients with cirrhosis.

Authors:  Nilgun Isiksalan Ozbulbul; Mehmet Yurdakul; Muharrem Tola
Journal:  Eurasian J Med       Date:  2014-10

Review 3.  Steatosis as a risk factor in liver surgery.

Authors:  Reeta Veteläinen; Arlène van Vliet; Dirk J Gouma; Thomas M van Gulik
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

Review 4.  Assessing the Non-tumorous Liver: Implications for Patient Management and Surgical Therapy.

Authors:  Pallavi Pandey; Ankur Pandey; Mary Dillhoff; Carl Schmidt; Ihab R Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-09-18       Impact factor: 3.452

5.  A diagnostic paradigm for resectable liver lesions: to biopsy or not to biopsy?

Authors:  Adrian B Cresswell; Fenella K S Welsh; Myrddin Rees
Journal:  HPB (Oxford)       Date:  2009-11       Impact factor: 3.647

6.  MR of the kidneys, liver, and spleen in paroxysmal nocturnal hemoglobinuria.

Authors:  M A Roubidoux
Journal:  Abdom Imaging       Date:  1994 Mar-Apr

Review 7.  New MR techniques for the detection of liver metastases.

Authors:  J Ward
Journal:  Cancer Imaging       Date:  2006-05-31       Impact factor: 3.909

8.  Hepatic subcapsular steatosis in a diabetic CAPD patient receiving intraperitoneal insulin.

Authors:  Eun Chul Jang; Guilsun Kim; Young Soo Kim; Sun Ae Yoon; Young Mi Ku; Chul Woo Yang; Young Ok Kim
Journal:  Korean J Intern Med       Date:  2006-09       Impact factor: 2.884

9.  Treatment of non-alcoholic fatty liver disease.

Authors:  Keith G Tolman; Anthony S Dalpiaz
Journal:  Ther Clin Risk Manag       Date:  2007-12       Impact factor: 2.423

10.  Hepatic metastasis disguised as fat spared area in the background of fatty liver: Detection on FDG PET/CT.

Authors:  Ameya D Puranik; Nilendu C Purandare; Archi Agrawal; Sneha Shah; Venkatesh Rangarajan
Journal:  Indian J Nucl Med       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.